A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome
about
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndromeHow do SSRIs help patients with irritable bowel syndrome?Abdominal bloating: pathophysiology and treatmentMain ion channels and receptors associated with visceral hypersensitivity in irritable bowel syndromePsychological approach to managing irritable bowel syndromeBloating in gastroparesis: severity, impact, and associated factorsReview article: the treatment of functional abdominal bloating and distension.Treatment of irritable bowel syndrome.Different faces of gastroparesis.Citalopram provides little or no benefit in nondepressed patients with irritable bowel syndrome.Pediatric functional gastrointestinal disorders.Relationship between use of selective serotonin reuptake inhibitors and irritable bowel syndrome: A population-based cohort studyIrritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicineThe psyche and the gut.Irritable bowel syndrome: a review article.Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases.Bloating and functional gastro-intestinal disorders: where are we and where are we going?The treatment of irritable bowel syndromeEffect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis.Efficacy and Safety of Antidepressants for the Treatment of Irritable Bowel Syndrome: A Meta-Analysis.Guidelines on the irritable bowel syndrome: mechanisms and practical management.The microbiome: stress, health and disease.Modulation of human serotonin transporter expression by 5-HTTLPR in colon cells.Stress and the Microbiota-Gut-Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome.Targeted therapies for diarrhea-predominant irritable bowel syndrome.Brain-Gut Interactions in IBSPain management in patients with inflammatory bowel disease: insights for the clinicianMechanisms of hypersensitivity in IBS and functional disorders.Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity.Serotonin receptor modulators in the treatment of irritable bowel syndrome.Mechanisms of serotonergic agents for treatment of gastrointestinal motility and functional bowel disorders.History of depressive and anxiety disorders and paroxetine response in patients with irritable bowel syndrome: post hoc analysis from a placebo-controlled study.Recent developments in the therapy of irritable bowel syndrome.How does cognitive behavior therapy for irritable bowel syndrome work? A mediational analysis of a randomized clinical trialNew treatments for irritable bowel syndrome in womenThe trials and tribulations of drug development for functional gastrointestinal disorders.A review of irritable bowel syndrome and an update on therapeutic approaches.Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.Management Strategies for Abdominal Bloating and Distension.Pain and inflammatory bowel disease.
P2860
Q24234934-C1A0D47F-BA8C-44D5-9DA4-4B6B54ABD06EQ24680167-3418F994-7619-43E6-B418-34C3AA21C316Q26851622-9207E5DB-643B-483B-AA1F-C351F4D8557DQ26862565-57A8002C-F816-4805-8614-D8944F07246AQ30479520-9CF6BB61-56CD-43F8-A4DB-A7F0F68D9475Q33450111-297A1B84-5049-4C87-B23F-8D5CF51E1FEDQ33450132-639CBFD7-6A5D-4C8D-8B83-E3DFEC6E1870Q33450370-BE44CDFC-94CA-473D-879B-6167FB7D4A50Q33555343-1C5103E8-791E-48CD-AFE4-775C2142A7AAQ33636450-784832CC-9EBF-4076-8464-F26470A3DFE5Q33651592-BBFF5043-1991-4433-B304-6EFC3C84BA7BQ33719985-4B30020F-93DA-4CE3-A2D6-80B04614A7F9Q33735229-ED996A1B-73FE-4811-A085-997D84184E9CQ34098603-8DDA157D-606D-4E57-81A1-825BB1B52697Q34134491-085C20EC-6257-49B7-ABFE-B2EF2D68F08BQ34318616-CB2D6D5D-03A6-465B-9701-3B6F7759A68BQ34366956-E668BA26-BDF4-4E6A-BD2D-DED1854459BAQ34409009-29B5D4E1-A309-44D7-A56A-DF39EB5F7857Q34425086-0B0FDB0A-EC90-4BB9-829D-F4718BB0EBE7Q34488657-5F751016-41A3-4534-8D85-3CD1DD9A8298Q34626602-8BE4EBAD-C178-46B1-8472-742AAB1610D5Q35054658-CE4DB72D-190A-4DAB-A864-F2EDBA8347B8Q35536026-6D1D6233-235B-40A5-8433-A7CCAEF9965CQ35867820-CC10EC00-0C49-4E3C-B869-9E16194ABE17Q36065945-682E6733-B12E-482C-B1A7-75041D675890Q36076024-CF8F798C-19C5-4924-BA82-385722690031Q36220453-FAEBC5F8-D55D-4CED-B888-91457E43C5E8Q36728934-6FF1CDE5-E53C-4CD6-8E6A-73FA7E37B06CQ36728938-C4D54583-53F2-4908-9517-ED48F31F1C70Q36822923-62864C92-6242-48FB-A0A1-1C908A01DBFEQ36874388-925FECDB-1029-426E-8343-550ABDDA196DQ37067979-266E4CB7-C913-4943-8EDB-4B40BE98C078Q37071175-5EC6CD87-0708-4FCC-AC49-F48AEBFA72EEQ37105074-09D3AA5A-3F73-4BAD-A55C-8101234E8D37Q37120300-8F5ECC01-1070-4665-B190-806D27DBA21CQ37134572-E5098715-C6E1-4E8C-8FE9-9A5F53E96566Q37142056-1F308873-5826-46CE-877B-99D147EFC3D1Q37164063-B141D16B-9E26-48C3-998A-941E5476B483Q37190545-94972E77-ECD1-4A14-A573-D4C74B55355DQ37364689-98C1E937-9E33-42B6-9802-14C55F818C60
P2860
A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A controlled crossover study o ...... am in irritable bowel syndrome
@ast
A controlled crossover study o ...... am in irritable bowel syndrome
@en
A controlled crossover study o ...... am in irritable bowel syndrome
@nl
type
label
A controlled crossover study o ...... am in irritable bowel syndrome
@ast
A controlled crossover study o ...... am in irritable bowel syndrome
@en
A controlled crossover study o ...... am in irritable bowel syndrome
@nl
prefLabel
A controlled crossover study o ...... am in irritable bowel syndrome
@ast
A controlled crossover study o ...... am in irritable bowel syndrome
@en
A controlled crossover study o ...... am in irritable bowel syndrome
@nl
P2093
P2860
P356
P1433
P1476
A controlled crossover study o ...... am in irritable bowel syndrome
@en
P2093
A M Gevers
B Fischler
D Broekaert
J Janssens
L Van Oudenhove
P2860
P304
P356
10.1136/GUT.2005.077503
P407
P577
2006-08-01T00:00:00Z